Trump confirms Makary out at FDA
President Donald Trump confirmed on Tuesday that Marty Makary would be leaving his post atop the U.S. Food and Drug Administration.
While speaking to reporters on the White House lawn Tuesday, Trump said Makary would be leaving. He said FDA deputy commissioner Kyle Diamantes will take over as the adminsitration seeks a new leader of the federal agency.
“He was having some difficulty,” Trump said. “Marty is a terrific guy, but he’s going to go and lead a good life.”
Trump did not specify what kind of difficulty Makary experienced. Several reports circulated that there was an internal dispute over approval for flavored vapes at the FDA. The Wall Street Journal reported that Trump pressured Makary to approve fruit-flavored vapes, but he was hesitant to do so.
Trump said many people are seeking the job atop the agency.
Makary was expected to testify on Capitol Hill Wednesday to present the FDA’s budget for the upcoming fiscal year. Diamantes is expected to take his place.
Makary was confirmed to lead the FDA in March 2025. Since then, he’s sought to make several changes to the agency’s policies and change organizational structure. Makary sought to limit antidepressants for pregnant women and ban kratom byproducts.
“He’s a friend of mine, he’s a wonderful man and he’s going to be off,” Trump said of Makary.
Latest News Stories
Michigan House Republicans demand Benson release SPLC records
Lone Tennessee U.S. House Democrat, Cohen, says he’s done
Illinois Quick Hits: Madigan: ‘Accept the federal scholarship tax credit’
Beecher Officials Lobby Springfield Legislators Against Governor’s “Build” Proposal
Will County Health Department Warns of Potential Federal Funding Cuts and Rising Healthcare Costs for FY2027
Highland Liquors Cleared for Video Gaming Expansion Following Zoning Approval
Lawmakers spar with Fairfax County leaders over sanctuary policies
Advocates call on tax reform to reduce national debt
Supreme Court allows mail-order abortion drugs
McCuskey, coalition of AGs urge SEC to review OpenAI
Springfield strains for balanced budget; Illinois revenue forecast shifts down
DOJ targets healthcare fraud in California, Arizona, Nevada